and scientific advisory boards for Eli Lilly, Novo Nordisk, Amgen, Pfizer, Currax, Calibrate, Vida Health, Ilant Health, Mellicell, Sweetch, Doximity, GoodRx, Empros Pharma, Clearmind Medicine, and Apnimed.The other authors report no disclosures
- 1015 IGF-1: mTOR, ,
Rising diabetes prevalence and expanding healthcare infrastructure are driving demand for GLP-1 drugs across pharmaceutical companies, healthcare providers, and digital health platforms throughout major Chinese healthcare centers
Dempster, J
Measurement Food 14:100157 Morya S, Menaa F, Jimnez-Lpez C, Loureno-Lopes C, BinMowyna MN, Alqahtani A (2022a) Nutraceutical and pharmaceutical behavior of bioactive compounds of miracle oilseeds: an overview